Xenon PharmaceuticalsXENE

那斯達克 · USD
55.63
-2.27
(-3.92%)
盤中 03/14 02:07 (UTC+8)
03/14 02:07 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • -
  • -
  • -
  • -
  • -
  • -
  • 0.08
  • 0.00
  • -
  • -
icon
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
營業收入淨額
-
-
0
7,500
-
-
-
-
-
-
營業成本
----------
營業毛利
-
-
0
7,500
-
-
-
-
-
-
營業費用
109,76796,33694,22980,23877,47773,67669,104-53,69555,684
研發費用
87,69977,05474,98561,20059,47256,97049,70244,25041,07642,880
推銷及管理費用
22,06819,28219,24419,03818,00516,70619,40214,79112,61912,804
非經常性項目費用
----------
其他營業費用
----------
營業利益
-109,767
-96,336
-94,229
-72,738
-77,477
-73,676
-69,104
-59,041
-53,695
-55,684
其他收入及費用
5,0446,117-8,1187,94410,56610,84711,5228,7477,065
利息費用
----------
稅前純益
-104,723
-90,219
-85,332
-64,620
-69,533
-63,110
-58,257
-47,519
-44,948
-48,619
所得稅
538677-626427-3,848-320-333412-205-157
稅後純益
-105,261
-90,896
-84,706
-65,047
-65,685
-62,790
-57,924
-47,931
-44,743
-48,462
基本每股稅後盈餘(元)
-1.31-1.15-1.07-0.83-0.84-0.81-0.75-0.62-0.64-0.73
稀釋每股稅後盈餘(元)
-1.31-1.15-1.07-0.83-0.84-0.81-0.74-0.62-0.64-0.73
基本平均股數(千股)
80126.0079247.0078953.0078687.0078386.0077926.0077671.0077594.0069968.0066002.00
稀釋平均股數(千股)
80126.0079247.0078953.0078687.0078386.0077926.0077671.0077594.0069968.0066002.00
還原基本每股稅後盈餘(元)
-1.31-1.15-1.07-0.83-0.84-0.81-0.75-0.62-0.64-0.73
還原稀釋每股稅後盈餘(元)
-1.31-1.15-1.07-0.83-0.84-0.81-0.74-0.62-0.64-0.73
還原基本平均股數(千股)
80,12679,24778,95378,68778,38677,92677,67177,59469,96866,002
還原稀釋平均股數(千股)
80,12679,24778,95378,68778,38677,92677,67177,59469,96866,002
EBITDA(千元)
-104,112-89,578-84,700-63,961-68,867-63,300-57,585-46,920-38,248-46,885

大家都在看

HOT